or Try an Advanced Search...

    Dna Synthesis Stocks List

    Symbol Grade Name % Change
    TWST F Twist Bioscience Corporation 2.72
    CYCCP F Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock 0.00
    CYCC F Cyclacel Pharmaceuticals, Inc. -7.89
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biology Biopharmaceutical Autoimmune And Inflammatory Disease Cancer Cancer Cell Cdk Inhibitor Cell Biology Cell Cycle Cell Cycle Checkpoint Cyclacel Cyclin Dependent Kinase Cyclin Dependent Kinase 2 Human Cancers Inflammatory Diseases PLK1 Sapacitabine Seliciclib Treatment Of Cancer Biotechnology Drug Discovery

    Related ETFs - A few ETFs which own one or more of the above listed Dna Synthesis stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 8.37
    WDNA D WisdomTree BioRevolution Fund 3.24
    EDOC C Global X Telemedicine & Digital Health ETF 2.9
    IDNA D iShares Genomics Immunology and Healthcare ETF 2.77
    ARKK B ARK Innovation ETF 1.8
    View all Dna Synthesis ETFs...
    Compare ETFs
    Compare ARKG to ARKK Compare ARKG to IDNA Compare WDNA to ARKK

        Dna Synthesis Stocks Recent News

        Date Stock Title
        Nov 20 TWST Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations
        Nov 20 TWST Twist Bioscience price target lowered to $52 from $55 at Barclays
        Nov 19 TWST Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 TWST Company News for Nov 19, 2024
        Nov 19 TWST Q4 2024 Twist Bioscience Corp Earnings Call
        Nov 19 TWST Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
        Nov 18 TWST Twist Bioscience: A Post-Earnings Assessment
        Nov 18 TWST Twist Bioscience rises 13% on FQ4 earnings beats, 2025 revenue outlook
        Nov 18 TWST Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps
        Nov 18 TWST Twist Bioscience Corporation (TWST) Q4 2024 Earnings Call Transcript
        Nov 18 TWST Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
        Nov 18 TWST Earnings Snapshot: Twist Bioscience tops FQ4 estimates; initiates FQ1 and FY25 outlook
        Nov 18 TWST Twist Bioscience: Fiscal Q4 Earnings Snapshot
        Nov 18 TWST Twist Bioscience GAAP EPS of -$0.59 beats by $0.11, revenue of $84.71M beats by $2.05M
        Nov 18 TWST Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
        Nov 18 TWST Earnings Scheduled For November 18, 2024
        Nov 15 TWST Twist Bioscience Q4 2024 Earnings Preview
        Nov 15 CYCCP Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations
        Nov 15 CYCC Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations
        Nov 14 CYCCP Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biology Biopharmaceutical Autoimmune And Inflammatory Disease Cancer Cancer Cell Cdk Inhibitor Cell Biology Cell Cycle Cell Cycle Checkpoint Cyclacel Cyclin Dependent Kinase Cyclin Dependent Kinase 2 Human Cancers Inflammatory Diseases PLK1 Sapacitabine Seliciclib Treatment Of Cancer Biotechnology Drug Discovery
        Dna Synthesis

        DNA synthesis is the process of creating a new strand of DNA from existing strands of DNA. It is a key process in the production of proteins and other molecules that are essential for life. DNA synthesis is carried out by enzymes called DNA polymerases, which use existing strands of DNA as templates to create new strands.

        Browse All Tags